A Novel Cascade Nanoreactor Integrating Two‐Dimensional Pd‐Ru Nanozyme, Uricase and Red Blood Cell Membrane for Highly Efficient Hyperuricemia Treatment

Abstract Nanozyme‐based cascade reaction has emerged as an effective strategy for disease treatment because of its high efficiency and low side effects. Herein, a new and highly active two‐dimensional Pd‐Ru nanozyme is prepared and then integrated with uricase and red blood cell (RBC) membrane to fabricate a tandem nanoreactor, Pd‐Ru/Uricase@RBC, for hyperuricemia treatment. The designed Pd‐Ru/Uricase@RBC nanoreactor displayed not only good stability against extreme pH, temperature and proteolytic degradation, but also long circulation half‐life and excellent safety. The nanoreactor can effectively degrade UA by uricase to allantoin and H 2 O 2 and remove H 2 O 2 by using Pd‐Ru nanosheets (NSs) with the catalase (CAT)‐like activity. More importantly, the finally produced O 2 from H 2 O 2 decomposition can in turn facilitate the catalytic oxidation of UA, as the degradation of UA is an O 2 consumption process. By integrating the high‐efficiency enzymatic activity, long circulation capability, and good biocompatibility, the designed Pd‐Ru/Uricase@RBC can effectively and safely treat hyperuricemia without side effects. The study affords a new alternative for the exploration of clinical treatment of hyperuricemia.